Navigation Links
ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI)
Date:12/4/2008

/www.exonhit.com

ExonHit Therapeutics is the world's leader in the analysis of alternative RNA splicing, a process which when deregulated plays a key role in the onset of various diseases.

ExonHit has a multi-component commercial strategy to capture the maximum value from its leadership in alternative splicing. The Company is already generating revenues from a new generation of microarrays, SpliceArrayTM family of products, that enable life science researchers to detect crucial disease-associated information. These products are marketed worldwide in conjunction with Agilent and Affymetrix. In the field of diagnostics, ExonHit has a major collaboration with bioMerieux to develop completely novel predictive blood-based cancer diagnostics, which could play a key role in improving the treatment of breast cancer and other major cancers.

In parallel, ExonHit is developing its own therapeutic pipeline in the field of neurodegenerative diseases and cancer. The Company has advanced drug candidates into clinical trials and is evaluating several promising pre-clinical compounds. ExonHit also has a strategic partnership with Allergan, to discover and develop new therapeutics in the areas of pain, neurological diseases and ophthalmology. This collaboration provides on-going research funding to ExonHit.

Founded in 1997, ExonHit is headquartered in Paris, France and has a U.S. facility in Gaithersburg, Maryland. The Company is listed on Alternext of Euronext Paris (ticker: ALEHT; ISIN: FR0004054427) since November 17, 2005.

This press release includes only summary information and does not purport to be comprehensive. The projections, forecast and estimates of ExonHit Therapeutics which may be contained herein are for illustrative purposes only and are based on management's current views and assumptions. Such projections, forecast and estimates involve known and unknown risks and uncert
'/>"/>

SOURCE ExonHit Therapeutics SA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies
2. Loic Maurel Joins Exonhit Therapeutics to Become CEO
3. ExonHit Launches Rat Genome SpliceArray(TM) Products to Expand High Resolution Gene Expression Profiling for use in Disease Modeling and Toxicogenomics
4. Frederic Desdouits Appointed Member of the Supervisory Board of ExonHit Therapeutics
5. ExonHit Appoints a New Management Board
6. ExonHit Therapeutics - 2007 Financial Results
7. ExonHit Builds A New Organisation
8. ExonHit and bioMerieux Amend Their Strategic Partnership
9. ExonHit Gets Regulatory Approval to Initiate a Phase 2 Clinical Trial for EHT 0202 in Alzheimers Disease
10. ExonHit Completes a Prototype to Detect Alzheimers Disease From Blood
11. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014  ARCH Venture Partners, one ... in the development of seed and early-stage advanced ... fund closed with more than $400 million in ... million subscription target by more than $150 million. ... the strength and potential of our approach to ...
(Date:8/27/2014)... Raton, FL (PRWEB) August 27, 2014 ... are applied through the use of a handheld spray, ... across the United States. , The brand began ... unit. BIOEQUA researchers were surprised to learn that the ... be made extremely small and delivered directly to skin's ...
(Date:8/27/2014)... 27, 2014 Remcom announces an update ... new features for the biomedical industry. The central ... Thermal Sensor, exclusive to the Bio-Pro version of the ... XFdtd, developed to calculate the biological effects of electromagnetic ... added to all versions to expand engineers’ post-processing options. ...
(Date:8/26/2014)... they believe is the thinnest-possible semiconductor, a new ... three atoms thick. , The University of Washington ... semiconductor materials can be connected in an atomically ... could be the basis for next-generation flexible and ... solar technologies. , "Heterojunctions are fundamental elements of ...
Breaking Biology Technology:Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3BIOEQUA'S EQUA ESSENTIAL Product Line Redefines Skin Care & Now Available in America 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 3Scientists craft atomically seamless, thinnest-possible semiconductor junctions 2
... at the University of Copenhagen has been chosen to ... Programme. The 2.5 million appropriation will aim to ... and the Nano-Science Center is the first Danish research ... Seventh Programme. , The goal of the research project ...
... - DuPont today congratulated,growers planting Pioneer(R) brand sorghum ... categories in the 2007 National Sorghum Producers, (NSP),Yield ... with Pioneer sorghum,hybrid 84G62., Farmers growing Pioneer ... contest segments. First-, second- and third-place national,honors were ...
... Diagnostics,Incorporated (NYSE: DGX ), the nation,s leading ... that its Board of,Directors declared a quarterly cash ... share, payable on January 23, 2008, to shareholders ... Diagnostics, Quest Diagnostics is the leading provider ...
Cached Biology Technology:DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest 2Quest Diagnostics Declares Quarterly Cash Dividend 2
(Date:8/27/2014)... greatest risk to Europe based upon a proxy for ... using a ,big data, approach to scientific research. , ... Global Health ranked the top 100 pathogens affecting humans ... system which, they believe, will help governments across the ... infectious diseases, including as a result of climate change, ...
(Date:8/27/2014)... exists as five strains, none of which have approved ... Sudan ebolavirus (SUDV). Although not the strain currently devastating ... recently as 2012. In a new study appearing in ... report a possible therapy that could someday help treat ... Jonathan Lai and colleagues explain that about 50-90 percent ...
(Date:8/27/2014)... health advocates, campaigns against trans-fats have largely succeeded ... taking aim at sugar for its potential contributions ... are still wrangling over the best way to ... an article in Chemical & Engineering News ... American Chemical Society. , In the article, Stephen ...
Breaking Biology News(10 mins):Big data approach identifies Europe's most dangerous human and domestic animal pathogens 2Potential therapy for the Sudan strain of Ebola could help contain some future outbreaks 2
... is giving the VIP treatment to laboratory mice in ... , VIP is not "very important person," but vasoactive ... gut, that is also made by a specialized group ... Washington University assistant professor of Biology in Arts & ...
... Opening the door to a new way of understanding ... group of researchers at Scripps Institution of Oceanography at ... groundbreaking analysis of the North Pacific Ocean and how ... study, published in the May 19 issue of the ...
... Biocenter, University of Helsinki, show that atomic structures can ... as fossils did for the dinosaurs and reptiles. Their ... Molecular Cell. , These "molecular fossils" also revealed ... same structure. One plausible explanation may be that viral ...
Cached Biology News:Discovery clarifies role of peptide in biological clock 2Scripps scientists find potential for catastrophic shifts in Pacific ecosystems 2Scripps scientists find potential for catastrophic shifts in Pacific ecosystems 3
Conveniently document gels, films and membranes with a high quality thermal printer. , Compact, footprint printer , Supplies 256 gray scale for high resolution, archive-quality thermal film prints...
... designer enzyme that enables RT-PCR in ... enzyme allows reverse transcription and PCR ... temperatures (65C), which helps to remove ... results in highly stringent, accurate annealing ...
... Lyophilized solid. Highly active enzyme useful ... of target substrates, and inhibitor screening. Specific ... is defined as the amount of enzyme that will ... hour at 37 C at saturated substrate concentrations. ...
Request Info...
Biology Products: